8 Coupons
marketwatch: "new migraine drugs have promise -- and a ,500 price tag." .
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv). .
.
.
.
.
.
.
.